Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00501280 · ClinicalTrials.gov registry record

Genetic Susceptibility in Migrant Farmworker Children

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
768
Enrollment target

NCT00501280: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT00501280 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 768 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00501280 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
768 participants
Enrollment target

Study Summary

Primary Objectives: 1. To test the hypothesis that children whose mothers are Migrant/Seasonal Farmworkers (MSFs) (occupationally-exposed to pesticides) may be at a higher risk for exhibiting mutagen-induced DNA damage than children whose mothers and fathers are not MSFs. 2. To test the hypothesis that MSF mothers (occupationally-exposed to pesticides) may be at a higher risk for exhibiting mutagen-induced DNA damage than mothers who are not MSFs. Secondary Objectives: 1. To test the hypothesis that both the extent of pesticide exposure and the type of polymorphisms in chemical detoxification genes and DNA repair genes contribute to the extent of cytogenetic damage found in children of MSF women. 2. To test the hypothesis that both the extent of pesticide exposure and the type of polymorphisms in chemical detoxification genes and DNA repair genes contribute to the extent of cytogenetic damage found in MSF mothers. 3. To test the hypothesis that the total concentration levels of organochlorine (OCP) and organophosphate (OP) pesticides will correlate with the mutagenic potency of the serum and urine of the children. 4. To test the hypothesis that the total concentration levels of OCP and OP pesticides will correlate with the mutagenic potency of the serum and urine of the mothers. 5. To test the hypothesis that inherited polymorphisms in the PON1 gene and its expression modulate the risk for OP genotoxicity measured by the inhibition of the acetylcholinesterase enzyme in MSF children. 6. To test the hypothesis that inherited polymorphisms in the PON1 gene and its expression modulate the risk for OP genotoxicity measured by the inhibition of the acetylcholinesterase enzyme in MSF mothers.

Interventions

  • BEHAVIORAL Interview

Trial Details

FieldValue
Enrollment Target 768 participants
Start Date 2004-06
Est. Completion 2013-02
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00501280 record still lists

NCT00501280 is an observational study that tracks outcomes without assigning an intervention. The registered 768 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.

NCT00501280 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00501280 about?

NCT00501280 is a clinical study titled "Genetic Susceptibility in Migrant Farmworker Children". Primary Objectives: 1. To test the hypothesis that children whose mothers are Migrant/Seasonal Farmworkers (MSFs) (occupationally-exposed to pesticides) may be at a higher risk for exhibiting mutagen-induced DNA damage than children whose mothers and fathers are not MSFs. 2. To test the hypothesis ...

What is the current status of trial NCT00501280?

This trial is currently completed. The enrollment target is 768 participants. The study started on 2004-06. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00501280?

The interventions under investigation include: Interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00501280?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05119556 · 768 participants · NA

    Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

  • NCT05404750 · 768 participants

    Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

  • NCT05660525 · 768 participants · NA

    Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

  • NCT06324357 · 768 participants · Phase 1

    Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00501280, the US trial registry maintained by the National Library of Medicine. NCT00501280 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.